Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saki Shimizu

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Aging and Disease|February 21, 2013
Improving the Treatment of Parkinson's Disease: A Novel Approach by Modulating 5-HT(1A) ReceptorsSaki Shimizu, Yukihiro Ohno
CNS & Neurological Disorders Drug Targets|July 13, 2013
Improving the treatment of schizophrenia: role of 5-HT receptors in modulating cognitive and extrapyramidal motor functionsSaki Shimizu, Yuto Mizuguchi, Yukihiro Ohno
Biological & Pharmaceutical Bulletin|September 3, 2013
Pathophysiological roles of serotonergic system in regulating extrapyramidal motor functionsYukihiro Ohno, Saki Shimizu, Kentaro Tokudome
International Journal of Molecular Sciences|October 13, 2021
Emerging Roles of Astrocyte Kir4.1 Channels in the Pathogenesis and Treatment of Brain DiseasesYukihiro Ohno, Naofumi Kunisawa, Saki Shimizu
International Journal of Molecular Sciences|October 26, 2018
Inwardly Rectifying Potassium Channel Kir4.1 as a Novel Modulator of BDNF Expression in AstrocytesYukihiro Ohno, Masato Kinboshi, Saki Shimizu
Frontiers in Pharmacology|October 15, 2019
Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side EffectsYukihiro Ohno, Naofumi Kunisawa, Saki Shimizu
Journal of Pharmacological Sciences|April 9, 2009
Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in miceYukihiro Ohno, Saki Shimizu, Junta Imaki
Virology|January 21, 2011
Stem cell-based anti-HIV gene therapyScott G Kitchen, Saki Shimizu, Dong Sung An
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 20, 2010
Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disordersSaki Shimizu, Ayaka Tatara, Junta Imaki, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 12, 2018
[Function of synaptic vesicle protein 2A (SV2A) as a novel therapeutic target for epilepsy]Kentaro Tokudome, Saki Shimizu, Tadao Serikawa, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Aging and Disease|February 21, 2013
Improving the Treatment of Parkinson's Disease: A Novel Approach by Modulating 5-HT(1A) ReceptorsSaki Shimizu, Yukihiro Ohno
CNS & Neurological Disorders Drug Targets|July 13, 2013
Improving the treatment of schizophrenia: role of 5-HT receptors in modulating cognitive and extrapyramidal motor functionsSaki Shimizu, Yuto Mizuguchi, Yukihiro Ohno
Biological & Pharmaceutical Bulletin|September 3, 2013
Pathophysiological roles of serotonergic system in regulating extrapyramidal motor functionsYukihiro Ohno, Saki Shimizu, Kentaro Tokudome
International Journal of Molecular Sciences|October 13, 2021
Emerging Roles of Astrocyte Kir4.1 Channels in the Pathogenesis and Treatment of Brain DiseasesYukihiro Ohno, Naofumi Kunisawa, Saki Shimizu
International Journal of Molecular Sciences|October 26, 2018
Inwardly Rectifying Potassium Channel Kir4.1 as a Novel Modulator of BDNF Expression in AstrocytesYukihiro Ohno, Masato Kinboshi, Saki Shimizu
Frontiers in Pharmacology|October 15, 2019
Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side EffectsYukihiro Ohno, Naofumi Kunisawa, Saki Shimizu
Journal of Pharmacological Sciences|April 9, 2009
Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in miceYukihiro Ohno, Saki Shimizu, Junta Imaki
Virology|January 21, 2011
Stem cell-based anti-HIV gene therapyScott G Kitchen, Saki Shimizu, Dong Sung An
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 20, 2010
Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disordersSaki Shimizu, Ayaka Tatara, Junta Imaki, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 12, 2018
[Function of synaptic vesicle protein 2A (SV2A) as a novel therapeutic target for epilepsy]Kentaro Tokudome, Saki Shimizu, Tadao Serikawa, et al.
Pageof 9